GPhA Waxman/Hatch Plan Would Use Bonds To Protect 180-Day Exclusivity

The Generic Pharmaceutical Association is proposing to change the Waxman/Hatch patent challenge process to use bonds posted by brand name companies as a substitute for market exclusivity to provide an incentive for generic companies.